[DPHARMA] QoQ Cumulative Quarter Result on 30-Sep-2017 [#3]

Stock
[DPHARMA] DUOPHARMA BIOTECH BERHAD
Announcement Date
17-Nov-2017
Admission Sponsor
-
Sponsor
-
Financial Year
31-Dec-2017
Quarter
30-Sep-2017 [#3]
Profit Trend
QoQ- 59.35%
YoY- 62.3%
Quarter Report
Latest QR
Upcoming QR
DPHARMA's Result
DPHARMA's Financial Summary
View:
Show?
Cumulative Result
30/06/18 31/03/18 31/12/17 30/09/17 30/06/17 31/03/17 31/12/16 CAGR
Revenue 257,250 133,259 467,987 355,734 240,355 120,994 312,940 -12.27%
PBT 26,170 13,255 51,796 38,971 24,764 11,176 31,479 -11.61%
Tax -5,184 -2,608 -9,696 -8,639 -5,559 -2,558 -4,653 7.49%
NP 20,986 10,647 42,100 30,332 19,205 8,618 26,826 -15.13%
-
NP to SH 20,986 10,782 42,492 30,622 19,217 8,618 27,115 -15.74%
-
Tax Rate 19.81% 19.68% 18.72% 22.17% 22.45% 22.89% 14.78% -
Total Cost 236,264 122,612 425,887 325,402 221,150 112,376 286,114 -12.01%
-
Net Worth 209,983 206,429 479,809 474,230 463,071 463,071 454,703 -40.33%
Dividend
30/06/18 31/03/18 31/12/17 30/09/17 30/06/17 31/03/17 31/12/16 CAGR
Div 4,199 - 23,711 - 6,973 - 18,132 -62.39%
Div Payout % 20.01% - 55.80% - 36.29% - 66.87% -
Equity
30/06/18 31/03/18 31/12/17 30/09/17 30/06/17 31/03/17 31/12/16 CAGR
Net Worth 209,983 206,429 479,809 474,230 463,071 463,071 454,703 -40.33%
NOSH 650,902 278,959 278,959 278,959 278,959 278,959 278,959 76.19%
Ratio Analysis
30/06/18 31/03/18 31/12/17 30/09/17 30/06/17 31/03/17 31/12/16 CAGR
NP Margin 8.16% 7.99% 9.00% 8.53% 7.99% 7.12% 8.57% -
ROE 9.99% 5.22% 8.86% 6.46% 4.15% 1.86% 5.96% -
Per Share
30/06/18 31/03/18 31/12/17 30/09/17 30/06/17 31/03/17 31/12/16 CAGR
RPS 91.88 47.77 167.76 127.52 86.16 43.37 112.18 -12.49%
EPS 3.22 3.82 15.09 10.87 6.88 3.43 9.62 -51.88%
DPS 1.50 0.00 8.50 0.00 2.50 0.00 6.50 -62.47%
NAPS 0.75 0.74 1.72 1.70 1.66 1.66 1.63 -40.48%
Adjusted Per Share Value based on latest NOSH - 278,959
30/06/18 31/03/18 31/12/17 30/09/17 30/06/17 31/03/17 31/12/16 CAGR
RPS 26.72 13.84 48.61 36.95 24.97 12.57 32.51 -12.28%
EPS 2.18 1.12 4.41 3.18 2.00 0.90 2.82 -15.80%
DPS 0.44 0.00 2.46 0.00 0.72 0.00 1.88 -62.12%
NAPS 0.2181 0.2144 0.4984 0.4926 0.481 0.481 0.4723 -40.34%
Price Multiplier on Financial Quarter End Date
30/06/18 31/03/18 31/12/17 30/09/17 30/06/17 31/03/17 31/12/16 CAGR
Date 29/06/18 30/03/18 29/12/17 29/09/17 30/06/17 31/03/17 30/12/16 -
Price 1.30 2.80 2.53 2.20 2.25 2.31 1.98 -
P/RPS 1.41 5.86 1.51 1.73 2.61 5.33 1.76 -13.77%
P/EPS 17.34 72.44 16.61 20.04 32.66 74.77 20.37 -10.20%
EY 5.77 1.38 6.02 4.99 3.06 1.34 4.91 11.39%
DY 1.15 0.00 3.36 0.00 1.11 0.00 3.28 -50.37%
P/NAPS 1.73 3.78 1.47 1.29 1.36 1.39 1.21 26.99%
Price Multiplier on Announcement Date
30/06/18 31/03/18 31/12/17 30/09/17 30/06/17 31/03/17 31/12/16 CAGR
Date 26/11/18 28/05/18 28/02/18 17/11/17 25/08/17 22/05/17 24/02/17 -
Price 1.08 3.35 2.97 2.20 2.03 2.32 2.23 -
P/RPS 1.18 7.01 1.77 1.73 2.36 5.35 1.99 -29.48%
P/EPS 14.41 86.67 19.50 20.04 29.47 75.10 22.94 -26.71%
EY 6.94 1.15 5.13 4.99 3.39 1.33 4.36 36.44%
DY 1.39 0.00 2.86 0.00 1.23 0.00 2.91 -38.97%
P/NAPS 1.44 4.53 1.73 1.29 1.22 1.40 1.37 3.38%

PBT = Profit before Tax, NP = Net Profit, NP to SH = Net Profit Attributable to Shareholder, Div = Dividend, NP Margin = Net Profit Margin, ROE = Return on Equity, NOSH = Number of Shares, RPS = Revenue per Share, EPS = Earning Per Share, DPS = Dividend Per Share, NAPS = Net Asset Per Share, EOQ = End of Quarter, ANN = Announcement, P/RPS = Price/Revenue per Share, P/EPS = Price/Earning per Share, P/NAPS = Price/Net Asset per Share, EY = Earning Yield, DY = Dividend Yield.

NOSH is estimated based on the NP to SH and EPS. Div is an estimated figure based on the DPS and NOSH. Net Worth is an estimated figure based on the NAPS and NOSH.

Div Payout %, NP Margin, ROE, DY, QoQ ⃤ & YoY ⃤ figures in Percentage; RPS, EPS & DPS's figures in Cent; and NAPS's figures in Dollar.

All figures in '000 unless specified.

Discussions
Be the first to like this. Showing 0 of 0 comments
Post a Comment